Company intelligence / Profile preview

Vivablast

Shanghai, Shanghai, Chinavivablast.com ↗

Ownership: Private
Employees: ~2063
Development stage: Commercial

Overview

Viva Biotech provides comprehensive contract research and development services from early-stage drug discovery through commercial manufacturing. The company has enabled numerous preclinical and clinical programs globally but does not itself own or market therapeutic products. It maintains a leading position in protein structure analysis and supports innovative biotech companies with both service-for-fee and equity-for-service models[2][4][8].

Modalities: Small moleculeBiologicPeptidesMonoclonal antibodyAntibody-drug conjugate (ADC)Protein (including recombinant protein)Antibody fragment (e.g., single-chain, bispecifics)RNA therapy (supported by platform capabilities)
Industry: Drug Discovery Services

Partnerships

DTx PharmaFocus-X Therapeutics

Beyond the preview

Go deeper on Vivablast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivablast.

Explore the full profile